Français
Español
English
Portuguese
‘Landmark’ Israeli Cancer Treatment Approved in US » MED–Cancer-Gene Therapy
Kite Pharma cell-therapy specialists at work. (Kite Pharma via AP, File)
Image metadata
Date Taken: 27-Feb-2017 16:20:37Copyright: Kite Pharma
Credit: AP
Title: MED--Cancer-Gene Therapy
Caption: FILE - In this May 2016 file photo provided by Kite Pharma, cell therapy specialists at the company's manufacturing facility in El Segundo, Calif., prepare blood cells from a patient to be engineered in the lab to fight cancer. On Wednesday, Oct. 18, 2017, the Food and Drug Administration approved sales of the therapy Yescarta, developed by Kite Pharma. It is the second gene therapy for U.S. patients _ the first one for adults _ a custom-made, one-time treatment for certain common types of the blood cancer lymphoma. (Kite Pharma via AP, File)
Shutter Speed: 0 seconds